Moderna on Twitter: "We just announced that the Moderna COVID-19 Vaccine retains neutralizing activity against emerging variants first identified in the U.K. and the Republic of South Africa. Read more: https://t.co/UCCvX0PrKV https://t.co/nCGl3hfhlU" /
Moderna sues Pfizer and BioNTech over coronavirus vaccine | Massachusetts | The Guardian
Moderna's COVID-19 vaccine to roll out across the US
Early Data Show Moderna's Coronavirus Vaccine Is 94.5% Effective - The New York Times
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine | National Institutes of Health (NIH)
Moderna says its vaccine for ages under 6 will be ready for U.S. review in June | Reuters
FDA expected to authorize Moderna, Pfizer-BioNTech Omicron boosters - POLITICO
U of T partners with Moderna to advance research in RNA science and technology
US opens second COVID boosters to 50 and up, others at risk | AP News
Moderna Drives Innovative Vaccine Development
Moderna booster candidate shows strong response against Omicron subvariants | Reuters
Moderna (MRNA) Says It's Suing Pfizer (PFE), BioNTech Over Covid Shots - Bloomberg
Moderna's COVID-19 vaccine found to be 94.5% effective in recent study | World Economic Forum
exposición Fotografía moderna y contemporánea | Artnexus
Moderna Vaccine More Effective Than Pfizer, J&J, Especially After 4 Months: CDC
Moderna, Inc. - Home | Facebook
Moderna bivalent Covid vaccine appears to work against omicron subvariants BA.4 and BA.5
Moderna sues Pfizer and BioNTech alleging patent infringement over Covid vaccine
FDA Approval Updates: Pfizer, Moderna, and J&J COVID-19 Vaccine - GoodRx
Moderna taps Kenya as site for $500M mRNA manufacturing facility | Fierce Pharma
How fast can the next coronavirus vaccines be made? | MIT Technology Review
Moderna COVID-19 Vaccine: Standing Orders for Administering Vaccine (Monovalent and Bivalent) • 18 Years of Age and Older
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters | AP News
